首页> Neurology and therapy> Characterizing the Journey of Early Alzheimer's Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence Study.

Characterizing the Journey of Early Alzheimer's Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marwan N,Sabbagh

第一单位： Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA.

作者： Marwan N,Sabbagh ^[1] ; Chenyue,Zhao ^[2] ; Malena,Mahendran ^[3] ; Se Ryeong,Jang ^[4] ; François,Laliberté ^[3] ; Hideki,Toyosaki ^[4] ; Kaixin,Zhang ^[3] ; Feride,Frech ^[4] ; Kavita V,Nair ^[5]

作者单位： Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA. ^[1] Eisai Inc., 200 Metro Blvd, Nutley, NJ, 07110, USA. Chenyue_Zhao@eisai.com. ^[2] Group d'analyse SRI, Montréal, QC, Canada. ^[3] Eisai Inc., 200 Metro Blvd, Nutley, NJ, 07110, USA. ^[4] Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. ^[5]

关键词 Administrative claims Alzheimer’s disease Diagnostic patterns Disease-modifying therapy Lecanemab Retrospective study Treatment patterns

DOI 10.1007/s40120-025-00756-4

PMID 40319433

发布时间 2025-05-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Neurology and therapy

2025年14卷3期

1115-1127页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Neurology and therapy

2025年14卷3期

1115-1127页

检索历史清除

Characterizing the Journey of Early Alzheimer's Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence Study.

Neurology and therapy

相似文献

同项目论文

Neurology and therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Characterizing the Journey of Early Alzheimer's Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence Study.

Neurology and therapy

相似文献

同项目论文

Neurology and therapy

相关期刊

检索历史清除